Literature DB >> 14759345

Cerebral Malaria.

Gretchen L. Birbeck1.   

Abstract

Successful management of cerebral malaria requires rapid diagnosis, initiation of appropriate antimalarial agents, and aggressive supportive care. The antimalarial used will depend on drug availability, with many of the most effective agents not routinely available in the US. The use of technologically advanced diagnostic studies, such as electroencephalogram, that are generally not available in malaria-endemic regions may aid in management. But other tests, such as advanced neuroimaging, may offer limited guidance because there are little data indicating the best management of conditions, such as increased intracranial pressure, focal edema, and microhemorrhages. Close clinical assessments and rapid initiation of proven therapies should be the focus of care, even when advanced resources are available. Given the mortality of this condition and the long-term neurologic morbidity seen in survivors, adjunctive therapies are clearly needed to improve patient outcomes. Until more data are available, much of the management of cerebral malaria will continue to be based on anecdote rather than evidence.

Entities:  

Year:  2004        PMID: 14759345     DOI: 10.1007/s11940-004-0022-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  33 in total

1.  Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.

Authors:  J Crawley; C Waruiru; S Mithwani; I Mwangi; W Watkins; D Ouma; P Winstanley; T Peto; K Marsh
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

Review 2.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

3.  Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria.

Authors:  B Mordmüller; P G Kremsner
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

4.  The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.

Authors:  M B van Hensbroek; A Palmer; E Onyiorah; G Schneider; S Jaffar; G Dolan; H Memming; J Frenkel; G Enwere; S Bennett; D Kwiatkowski; B Greenwood
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 5.  Steroids for treating cerebral malaria.

Authors:  K Prasad; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  The 1996 Runme Shaw Memorial Lecture: malaria--past, present and future.

Authors:  D A Warrell
Journal:  Ann Acad Med Singapore       Date:  1997-05       Impact factor: 2.473

7.  Intracranial pressure in African children with cerebral malaria.

Authors:  C R Newton; F J Kirkham; P A Winstanley; G Pasvol; N Peshu; D A Warrell; K Marsh
Journal:  Lancet       Date:  1991-03-09       Impact factor: 79.321

8.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

Review 9.  Neurological sequelae of cerebral malaria in children.

Authors:  D R Brewster; D Kwiatkowski; N J White
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

Review 10.  Malaria pathogenesis.

Authors:  L H Miller; M F Good; G Milon
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.